logo
episode-header-image
Oct 2020
13m 43s

Operation Warp Speed's Moncef Slaoui on ...

AXIOS
About this episode
Pfizer today said it won't apply for an emergency use authorization for its COVID-19 vaccine until late November, all but guaranteeing that the FDA won't be asked to consider approval until after the election. Dan is joined by Moncef Slaoui, the White House's chief scientific advisor to Operation Warp Speed, the public-private partnership created to get a co ... Show More
Up next
Dec 2021
2021's challenges for journalism
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right a ... Show More
18m 20s
Dec 2021
The year psychedelics went mainstream
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major ... Show More
11m 21s
Dec 2021
Behind the scenes of How It Happened Season 3
Axios Re:Cap presents a conversation between Axios Today host Niala Boodhoo and Axios Tel Aviv reporter Barak Ravid about the third season of How It Happened: Trump's Big Deal. 
10m 56s
Recommended Episodes
May 2023
Drugmakers Face Ongoing Vaccine Hesitancy
P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the ... Show More
19m 55s
Jan 2021
Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it m ... Show More
15m 44s
May 2021
Biden administration on vaccine doses: Use it or lose it! Plus, should the U.S. share its vaccine doses with struggling countries?
The Biden administration is changing its vaccine distribution plan. Will it lead to more shots into arms?Should the U.S. ship more vaccine doses to struggling countries?A city in southern California is already planning on how to best distribute Pfizer vaccines for kids.The pandem ... Show More
23m 45s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
39m 42s
Sep 2020
Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?
As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a joint statement pledging to not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown ... Show More
12m 50s
Dec 2020
Why Did the U.S. Turn Down Vaccine Doses?
From the start of the pandemic, the Trump administration said it was committed to ordering and stockpiling enough potential vaccine doses to end the outbreak in the United States as quickly as possible.But new reporting from The Times has revealed that Pfizer, the maker of the fi ... Show More
25m 38s
Nov 2020
A Vaccine Breakthrough
It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 per ... Show More
24m 29s
Listen to millions of songs and podcasts on Anghami